YY/T 0456.1-2003
Replaced
T/CAME 38-2021
Active
Group standards
T/CAME 38-2021 Performance validation of nucleic acid testing for blood screening
T/CAME 38-2021 Performance validation of nucleic acid testing for blood screening
Price:
$ 20.00
Basic Information
Standard Code:
T/CAME 38-2021
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medical devices
ICS Name:
Laboratory medicine
Publish Date:
2021-07-15
Implement Date:
2021-07-15
Scope
Main technical content: This document specifies the verification requirements and verification methods involved in the performance verification of nucleic acid detection for blood screening. This document is applicable to nucleic acid detection laboratories in blood collection and supply institutions, medical institutions, and disease control centers, etc. Note: In this document, nucleic acid detection for blood screening primarily refers to the screening and detection of nucleic acids of pathogens transmitted through blood transfusion.
Development Information
Related Standards
YY/T 0456.2-2003
Replaced
YY/T 0456.2-2003 Regents for hematology analyzer use—Part 2:Hemolysin
YY/T 0456.3-2003
Replaced
YY/T 0456.3-2003 Regents for hematology analyzer use—Part 3:Diluent
YY/T 0475-2004
Replaced
YY/T 0475-2004 General technical requirements for urine analyzer
YY/T 0478-2004
Replaced
YY/T 0478-2004 General technical requirements for chemical reagent strips for urinalysis
YY/T 0032-2004
Active